Biostatistics has always been a central part of the statistics department. Its important role is emphasised by the direct allocation of three professors and the cooperation of other departments in research projects with biostatistical topics.
The Department of Statistics works in all areas of biostatistics including teaching, research and consultancy. A more detailed description of current research projects can be found by following the link: Areas of Research.
In the course of study at the department, biometrics is clearly the most commonly chosen of the possible focuses; Biometrics, Econometrics, Technometrics and Official Statistics. After completing their studies, more than a third of the statistics alumni work on key points for the development and application of biostatistical methods, in both university and non university settings, especially pharmaceutical industry, commissioned research institutes, in health-care and universities and research institutes.
Biostatistics is concerned with multifaceted questions. Historically, we understand biostatistics as statistical theory and methods of describing, analysing, and interpreting biological data. Today, we see a much wider field, with applications in all life sciences, especially in medicine and bioinformatics.
The classification of biostatistics into the most important areas of clinical statistics, epidemiology, toxicology and bioinformatics contains overlaps and does not cover all active working fields of the statistics department, but can be used as a basic representation of our work. For example, personalised medicine and genetic epidemiology have an interest in the genetic factors in clinical statistics and epidemiology. Also liver toxicological questions play an important role. This is why modern bioinformatic methods are needed.
Clinical statistics investigate the effect of clinical parameters on the diagnosis and treatment of human diseases. In the case of clinical trials, this happens in a controlled environment. Clinical trials are obligatory in most countries to test prescription drugs before they are released to the market.